HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Unilever NV

Beauty Market News: China Cosmetics Regulations Modernized, Florida Stops Local Oxybenzone Bans, More

L’Oreal acquires Thayers Natural Remedies; Unilever, L’Oreal remove ‘whitening,’ ‘fair’ from labels; China finalizes modernization of cosmetics regulations; and Florida governor signs law preventing local bans on oxybenzone.

Cosmetics Deals

Unilever’s Post-Crisis Outlook: Consumers Will Trade Down, Stay Online In Global Recession

Unilever is not providing fiscal 2020 guidance at the moment amid so many COVID-19 unknowns. However, leadership did offer predictions during the firm’s first-quarter earnings call as to how the pandemic is likely to have lasting effects on consumer behavior and the global marketplace.

Beauty Coronavirus COVID-19

Unilever Hit With Class Action Over Mercury-Laced Cream Originating In Mexico

According to the plaintiff, Unilever’s Pond’s Rejuveness Anti-Wrinkle Cream is defective insofar as tested product has been found to contain unlabeled mercury, constituting negligence that has resulted in user injuries. The plaintiff seeks certification of a transnational class and compensatory and punitive damages, among other relief.

United States Mexico

Grooming Investments Pay Off, Merck OTCs Count Organically In P&G's Latest Quarter

P&G’s grooming segment grew 4% in its latest quarter, the third consecutive of organic growth as the Gillette brand wins 18m customers in 12 months. The results suggest investments the company made to ward off subscription-based competitors are starting to pay off.

Sales & Earnings OTC Drugs
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Services
  • Pharmaceuticals
    • Nutraceuticals
    • OTC, Consumer
    • Specialty Pharmaceuticals
UsernamePublicRestriction

Register